Skip to main content

Table 1 Patient demographics and tumor characteristics

From: One-and-a-half nostril endoscopic transsphenoidal approach for pituitary adenomas—a technical report

Patient age, mean ± SD, y 49.7 ± 14.1
Male/female, n 35/22
Follow up (range), mo 18 (6–24)
Tumor with volumes mm3 22*20*20
Recurrent, n (%) 7 (12.3%)
Presenting symptoms, n (%)
 Abnormal visual functions 32 (56%)
 Endocrinopathy 18 (32%)
 Headache 13 (23%)
 Incidental 7 (12%)
 Pituitary apoplexy 6 (11%)
Knosp score, n (%)
 0 3 (5.3%)
 1 8 (14.0%)
 2 16 (28.1%)
 3 19 (33.3%)
 4 11 (19.3%)
Nonfunctioning adenoma, n (%) 39 (68.4%)
Functioning adenoma, n (%) 18 (31.6%)
Growth hormone 12 (21.1%)
Prolactinomas 4 (7.0%)
ACTH 2 (3.5%)